Elevated serum or urinary LCN2 levels are associated with atherosclerosis risk factors, disease severity and mortality, with studies suggesting that LCN2 could serve as a prognostic marker with patients presenting with acute coronary syndromes [114,115]. This evidence concerns the gene LCN2 and acute coronary syndrome.